“…In the past decade, oral films have emerged as a novel solid dosage form that shows great potential over other solid dosage forms for the delivery of poorly water-soluble drugs. ,, Their large surface area-to-volume ratios enable the rapid dissolution and absorption of drugs in the gastrointestinal tract, leading to significantly increased bioavailability . In addition, they are easy to swallow and thus show exceptional acceptability for geriatric, pediatric, and dysphagic patients. , In a typical film-forming process, a nanosuspension is first prepared and then mixed with a film-forming polymer solution to form a film precursor for casting and drying. − Wet stirred media milling is one of the most extensively used techniques to formulate nanoparticle suspensions because it is a robust and well-established process that can be applied to many hydrophobic drugs. , However, it generally involves long milling durations (3–12 h), , and the erosion of milling media may cause severe contamination of drugs. , In addition, irreversible nanoparticle aggregation during long-time processing and drying is still a common problem that can reduce the dissolution rate of drug nanoparticles and negatively affect the drug uniformity in oral films. , The aggregation problem becomes even more prominent when more drug nanoparticles are incorporated in oral films, rendering the oral film technology limited to low drug loading capacity. , Other film-forming technologies involve the incorporation of amorphous solid dispersions − and solid lipid nanoparticles, − both of which provide improved bioavailability of poorly water-soluble drugs. However, amorphous solid dispersions are susceptible to recrystallization that undermines the drug efficacy, , and the recrystallization becomes more significant with increasing drug loadings .…”